Investing.com - Quest Diagnostics (NYSE:DGX) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Quest Diagnostics announced earnings per share of $2.36 on revenue of $2.49. Analysts polled by Investing.com anticipated EPS of $2.17 on revenue of $2.33B.
Quest Diagnostics shares are down 26% from the beginning of the year, still down 27.27% from its 52 week high of $174.16 set on December 31, 2021.
Quest Diagnostics follows other major Healthcare sector earnings this month
Quest Diagnostics's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar